OPTIMUM PHENYTOIN-DOSAGE REGIMENS
- 1 February 1976
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 307 (7954) , 307-308
- https://doi.org/10.1016/s0140-6736(76)91441-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- PHENYTOIN DOSAGE NOMOGRAMThe Lancet, 1975
- SERUM-PHENYTOIN LEVELSThe Lancet, 1975
- Malignant lymphoma after diphenylhydantoin (dilantin) therapyCancer, 1975
- SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSYThe Lancet, 1975
- Diphenylhydantoin elimination kinetics in overdosed childrenClinical Pharmacology & Therapeutics, 1975
- PHENYTOIN DOSE ADJUSTMENT IN EPILEPTIC PATIENTSBritish Journal of Clinical Pharmacology, 1974
- Pharmacokinetic study of a patient with diphenylhydantoin toxicityClinical Pharmacology & Therapeutics, 1973
- DEPRESSION OF IMMUNOLOGICAL FUNCTION IN PATIENTS TREATED WITH PHENYTOIN SODIUM (SODIUM DIPHENYLHYDANTOIN)The Lancet, 1971
- Malignant Lymphoma Associated With Hydantoin DrugsArchives of Neurology, 1970
- Management of Epilepsy With Diphenylhydantoin SodiumPublished by American Medical Association (AMA) ,1968